The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up. The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
48
Geriatric evaluation with MMS, GDS and ADL scoring
evaluation of cognitive functions, psychological functions, dependency in activities, vision, audition, mobility and nutritional status : only at the first visit
evaluation of cognitive functions, psychological functions, dependency in activities, vision, audition, mobility and nutritional status : every 6 month for 3 years
CHU de Nice
Nice, France
death
Time frame: every 6 month for 3 years since inclusion
occurrence of a severe dementia (MMS < 10)
Time frame: every 6 month for 3 years since inclusion
major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria
Time frame: every 6 month for 3 years since inclusion
severe dependency (ADL < 3/6)
Time frame: every 6 month for 3 years since inclusion
cognitive, psychic and autonomy scores
Time frame: every 6 month for 3 years since inclusion
cardiovascular morbidity and mortality
Time frame: every 6 month for 3 years since inclusion
bone fracture
Time frame: every 6 month for 3 years since inclusion
nutritional parameters
Time frame: every 6 month for 3 years since inclusion
dialysis parameters
Time frame: every 6 month for 3 years since inclusion
biological follow-up of chronic kidney disease including haemoglobin level
Time frame: every 6 month for 3 years since inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.